For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
Menu
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
For Institutions
GMP Products & Services
Research-Grade Products & Services
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Media Coverage/Awards
Careers
Contact Us
English
日本語
Icon-twitter-x
Facebook-f
Latest in Regenerative Medicine
All
Cancer
Heart Disease
Ophthalmic / Neurological Disorders
Other
Anti-cancer therapeutic potential of tumoricidal T cells regenerated from tumor-infiltrating lymphocyte-derived iPS cells
•
October 19, 2021
•
Cancer
The iPSC-based cancer vaccine prevents tumor growth in pancreatic cancer (Published in 2020)
•
July 6, 2021
•
Cancer
Successful reconstruction of a three-Dimensional structure resembling a human embryo from iPS cells
•
May 5, 2021
•
Other
Artificially cultured brains mature much like infant brains (Published in 2021)
•
March 26, 2021
•
Ophthalmic / Neurological Disorders
Autologous transplantation of iPS cell-derived dopaminergic neurons alleviates motor and depressive behaviors in Parkinson’s model monkeys
•
March 19, 2021
•
Ophthalmic / Neurological Disorders
The University of Arizona developed a human iPS cell-derived cardiomyocyte patch for the treatment of heart failure (Published in 2019)
•
March 12, 2021
•
Heart Disease
Kyoto University has generated iPS cells with less risk of rejection by genome editing
•
March 1, 2021
•
Cancer
Kyoto University has succeeded in regenerating T-cells from human iPS cells that enhance effects of cancer immunotherapy(2018)
•
February 22, 2021
•
Cancer
Kyoto University developed a scalable method to regenerate T-cells from iPSCs
•
February 3, 2021
•
Cancer
Alzheimer’s patient iPS-derived neurons lead to the discovery of genetic mechanisms underlying the cause of disease.
•
December 4, 2020
•
Ophthalmic / Neurological Disorders
Reach out to us to learn more
Contact Us